Corvus Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Corvus Pharmaceuticals Inc
CIK #0001626971
EDGAR Form CIK 2011 - 2026
10-K [0001626971]
10-Q [0001626971]
3 [0001626971]
4 [0001626971]
5 [0001626971]
8-K [0001626971]
D [0001626971]
SC 13D [0001626971]
SC 13G [0001626971]
Form 13D/13G Filer Form 13D/13G Subject Filed
Sirenia Capital Management LP Corvus Pharmaceuticals Inc [2026-05-15]
Vanguard Group Inc Corvus Pharmaceuticals Inc [2026-01-30]
BlackRock Inc Corvus Pharmaceuticals Inc [2025-10-17]
Point72 Asset Management LP Corvus Pharmaceuticals Inc [2024-05-09]
Samlyn Capital LLC Corvus Pharmaceuticals Inc [2024-02-14]
CHI Advisors LLC Corvus Pharmaceuticals Inc [2023-02-13]
Integrated Core Strategies US LLC Corvus Pharmaceuticals Inc [2021-12-06]
Integrated Core Strategies US LLC Corvus Pharmaceuticals Inc [2021-10-22]
Venrock Healthcare Capital Partners II LP Corvus Pharmaceuticals Inc [2021-09-30]
Tang Capital Partners LP Corvus Pharmaceuticals Inc [2021-09-22]
EcoR1 Capital LLC Corvus Pharmaceuticals Inc [2021-05-11]
Price T Rowe Associates Inc /MD/ Corvus Pharmaceuticals Inc [2019-02-14]
Adams Street Partners LLC Corvus Pharmaceuticals Inc [2018-03-21]
Biotechnology Value Fund L P Corvus Pharmaceuticals Inc [2018-03-19]
Adams Street Partners LLC Corvus Pharmaceuticals Inc [2017-02-13]
FMR LLC Corvus Pharmaceuticals Inc [2016-08-10]
Miller Richard A MD Corvus Pharmaceuticals Inc [2016-04-08]
OrbiMed Advisors LLC Corvus Pharmaceuticals Inc [2016-04-01]
Novo A/S Corvus Pharmaceuticals Inc [2016-03-30]
Form 3/4/5 Subject 2011 - 2026
Corvus Pharmaceuticals Inc
Thompson Peter A
van den Broek Richard
Clark Ian T
Moore David Scott
Grais Linda
Miller Richard A MD
Chan Andrew C
Jones William Benton
Arcara Jeffrey
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Corvus Pharmaceuticals Inc CRVS
Common Stock
2026-01-28 Option exercise 15,000 $2.49 37,350
Corvus Pharmaceuticals Inc CRVS
Common Stock
2026-01-28 Option exercise 15,000 $9.70 145,500
Corvus Pharmaceuticals Inc CRVS
Common Stock
2026-01-28 Option exercise 30,000 $15.00 450,000
Corvus Pharmaceuticals Inc CRVS
Common Stock
2026-01-28 Option exercise 15,000 $3.61 54,150
Corvus Pharmaceuticals Inc CRVS
Common Stock
2026-01-28 Option exercise 15,000 $2.00 30,000
Corvus Pharmaceuticals Inc CRVS
Common Stock
2026-01-28 Option exercise 15,000 $3.27 49,050
Corvus Pharmaceuticals Inc CRVS
Common Stock
2026-01-28 Option exercise 15,000 $2.12 31,800
Corvus Pharmaceuticals Inc CRVS
Common Stock
2026-01-28 Option exercise 15,000 $2.60 39,000
Corvus Pharmaceuticals Inc CRVS
Common Stock
2026-01-28 Option exercise 15,000 $0.99 14,850
Corvus Pharmaceuticals Inc CRVS
Common Stock
2026-01-28 Option exercise 15,000 $0.97 14,550
Corvus Pharmaceuticals Inc CRVS
Common Stock
2026-01-28 Option exercise 15,000 $1.64 24,600
Corvus Pharmaceuticals Inc CRVS
Common Stock
2026-01-28 Option exercise 15,000 $2.74 41,100
Corvus Pharmaceuticals Inc CRVS
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 15,000 $0.00
Corvus Pharmaceuticals Inc CRVS
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 15,000 $0.00
Corvus Pharmaceuticals Inc CRVS
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 15,000 $0.00
Corvus Pharmaceuticals Inc CRVS
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 15,000 $0.00
Corvus Pharmaceuticals Inc CRVS
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 15,000 $0.00
Corvus Pharmaceuticals Inc CRVS
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 15,000 $0.00
Corvus Pharmaceuticals Inc CRVS
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 30,000 $0.00
Corvus Pharmaceuticals Inc CRVS
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 15,000 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com